BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1640215)

  • 1. Cytochrome P450. Mechanisms of action and clinical implications.
    Williams MT
    J Fla Med Assoc; 1992 Jun; 79(6):405-8. PubMed ID: 1640215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
    Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y
    Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forty years of cytochrome P450.
    Omura T
    Biochem Biophys Res Commun; 1999 Dec; 266(3):690-8. PubMed ID: 10603307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds.
    Shimada T; El-Bayoumy K; Upadhyaya P; Sutter TR; Guengerich FP; Yamazaki H
    Cancer Res; 1997 Nov; 57(21):4757-64. PubMed ID: 9354437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications.
    Zhang YY; Yang L
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):621-9. PubMed ID: 19473111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
    Shimada T; Mernaugh RL; Guengerich FP
    Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals.
    Wolf CR
    IARC Sci Publ; 1991; (115):281-7. PubMed ID: 1820342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on PCB toxicity involving 2C subfamily cytochrome P450].
    Ariyoshi N; Ito S; Okudaira A; Mise M; Matsusue K; Yamada H; Oguri K
    Fukuoka Igaku Zasshi; 1995 May; 86(5):153-62. PubMed ID: 7628802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the cytochrome P450 system as a mechanism of chemoprotection.
    Wolf CR; Mahmood A; Henderson CJ; McLeod R; Manson MM; Neal GE; Hayes JD
    IARC Sci Publ; 1996; (139):165-73. PubMed ID: 8923029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome p450 and chemical toxicology.
    Guengerich FP
    Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytochrome P450 monooxygenases in microbial fatty acid metabolism.
    Van Bogaert IN; Groeneboer S; Saerens K; Soetaert W
    FEBS J; 2011 Jan; 278(2):206-21. PubMed ID: 21156025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytochrome P450 in tumour development and progression and its potential in therapy.
    Murray GI
    J Pathol; 2000 Dec; 192(4):419-26. PubMed ID: 11113857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
    Yamazaki H; Shaw PM; Guengerich FP; Shimada T
    Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
    Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
    Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 isoforms. Regulation during infection, inflammation and by cytokines.
    Williams JF
    J Fla Med Assoc; 1991 Aug; 78(8):517-9. PubMed ID: 1720447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms that regulate production of reactive oxygen species by cytochrome P450.
    Zangar RC; Davydov DR; Verma S
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):316-31. PubMed ID: 15364547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
    Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
    Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.